Unsere Webseite nutzt Cookies, damit die User-Experience gesteigert wird. Bitte beachten Sie, dass ohne Cookies einige Funktionalitäten nicht mehr ausführbar sind (z.B. Formulare). Ausführlichere Hinweise zu Cookies
OK
Welcome to the Institute of Clinical Neuroimmunology
National MS society awards research grant to Anneli Peters and Lisa-Ann Gerdes
Klaus Faber Initiative for Progressive MS funded at the Institute of Clinical Neuroimmunology
January 2022:Our group leaders Anneli Peters and Lisa Ann Gerdes won a highly competitive research grant of 297.000 USD from the US-American National Multiple Sclerosis Society (NMSS).
November 2021: The Klaus Faber foundation has funded a new research initiative at the Institute of Clinical Neuroimmunology that aims to uncover disease driving mechanisms in multiple sclerosis.
Broader Epstein–Barr virus–specific T cell receptor repertoire in the MS TWIN STUDY
Longitudinal retinal changes in MOGAD
September 2022 - Epstein–Barr virus (EBV) infection precedes multiple sclerosis (MS) pathology and cross-reactive antibodies might link EBV infection to CNS autoimmunity. As an altered anti-EBV T cell reaction was suggested in MS, in collaboration with the Institute of Translational Neurology in Münster, the Gerdes Lab queried peripheral blood T cell ...
July 2022 - In contrast to multiple sclerosis, it was not sufficiently investigated whether patients with myelin-oligodendrocyte-glycoprotein-antibody (MOG-IgG)-associated disease (MOGAD) also show a relapse-independent, subclinical retinal neuro-axonal loss. Therefore, initiated by @NeuroVisionLab (Havla Lab), eighty patients ...
